BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2008
View Archived Issues
Responses to nemifitide seen in patients with severe, refractory depression
Read More
Volociximab-gemcitabine combination feasible in metastatic pancreatic cancer
Read More
Satisfactory therapeutic window of Micromet's BiTE antibody muS-110
Read More
Small molecule CCR3 antagonist shows preclinical efficacy for the treatment of asthma
Read More
New agents for treating neurological disorders described in recent patent literature
Read More
Once-daily mesalamine for active ulcerative colitis now available in Canada
Read More
New anticancer agents disclosed in recent patents
Read More
Theratechnologies reviews strategic alternatives to enhance shareholder value
Read More
Topigen initiates European phase II trial of TPI-ASM-8 in asthma patients
Read More
Lipid reports favorable results from preclinical study of delipidated autologous virus vaccine
Read More
Phase II trial demonstrates Davanat's benefits in combination with other chemotherapeutics
Read More
Ipsen withdraws application to EMEA for extension of indication for Nutropin AQ
Read More
Oasmia receives final advice from EMEA regarding phase III program for Paclical
Read More
FDA grants priority review for Millennium's Velcade for multiple myeloma
Read More
DOR BioPharma achieves 2-year stability milestone for its ricin toxin vaccine
Read More
FDA issues nonapprovable letter to Impax for Vadova for Parkinson's disease
Read More
Tigris Pharmaceuticals initiates phase I study of AFP-464 for treatment of solid tumors
Read More
Phosphagenics announces results from preclinical study of APA-01 and atorvastatin
Read More
First patients treated in Cytori's stem and regenerative cell heart attack study
Read More
Banyu obtains additional indication approval for Singulair in allergic rhinitis
Read More
Somaxon submits NDA for Silenor, a drug candidate for insomnia therapy
Read More
Novel agents for arthritic disorders disclosed in recent patents
Read More
GlaxoSmithKline obtains approval for Amerge in Japan
Read More